Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Conserved N-terminal cysteine dioxygenases transduce responses to hypoxia in animals and plants
2019 StandoutScienceNobel
Motor neurons control blood vessel patterning in the developing spinal cord
2017
Hallmarks of Cancer: The Next Generation
2011 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Heterogeneity of the Tumor Vasculature
2010
EGFR Antagonists in Cancer Treatment
2008 Standout
Osteoporosis
2019 Standout
Estrogen receptors and human disease
2006 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
The shunt problem: control of functional shunting in normal and tumour vasculature
2010
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Host tissue determinants of tumour immunity
2019
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Lung Cancer
2008 Standout
Therapeutic uses of vitamin D analogues
2001
Hypoxia and Inflammation
2011 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Gpr124 Controls CNS Angiogenesis and Blood-Brain Barrier Integrity by Promoting Ligand-Specific Canonical Wnt Signaling
2014
The biology and function of fibroblasts in cancer
2016 Standout
Vitamin D Deficiency
2007 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Immunological hallmarks of stromal cells in the tumour microenvironment
2015
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
Targeting Tumor Mitochondrial Metabolism Overcomes Resistance to Antiangiogenics
2016
Nanomaterials for cancer immunotherapy
2017
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
The epidemiology of vitamin D and cancer incidence and mortality: A review (United States)
2005
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
2018
The golden age: gold nanoparticles for biomedicine
2011 Standout
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
2015
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Emerging Biological Principles of Metastasis
2017 Standout
The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen
1998 Standout
Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
2006
GPR124 Functions as a WNT7-Specific Coactivator of Canonical β-Catenin Signaling
2014
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Modern Synthetic Methods for Fluorine‐Substituted Target Molecules
2004 Standout
The Neurovascular Link in Health and Disease: Molecular Mechanisms and Therapeutic Implications
2011
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Vascular normalization in Rgs5-deficient tumours promotes immune destruction
2008 Nature
TRPA1 Mediates the Inflammatory Actions of Environmental Irritants and Proalgesic Agents
2006 StandoutNobel
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Pericytes regulate the blood–brain barrier
2010 StandoutNature
Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S
2014
Molecular and cellular biomarkers for angiogenesis in clinical oncology
2007
Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)
2000
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Modes of resistance to anti-angiogenic therapy
2008 Standout
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
2012 StandoutNobel
Endothelial oxygen sensors regulate tumor vessel abnormalization by instructing phalanx endothelial cells
2009
The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women
1999
Tumor Angiogenesis
2008 Standout
Roles of PPARs in health and disease
2000 StandoutNature
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
Wiring the Vascular Network with Neural Cues: A CNS Perspective
2015
Effects of Raloxifene on Serum Lipids and Coagulation Factors in Healthy Postmenopausal Women
1998
Antiestrogenic Action of Raloxifene and Tamoxifen: Today and Tomorrow
1998
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
Selective Estrogen-Receptor Modulators for Primary Prevention of Breast Cancer
2005
Targeting of drugs and nanoparticles to tumors
2010
Binaphthol-titanium-promoted, highly enantiocontrolled, Diels-Alder cycloadditions of electronically matched 2-pyrones and vinyl ethers: Streamlined asymmetric synthesis of an A-ring precursor to physiologically active 1α-hydroxyvitamin D3 steroids
1994
Hazardous air pollutants and asthma.
2002
BINOL: A Versatile Chiral Reagent
2005 Standout
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 1. Receptor Interactions
2003
Wound Healing: A Cellular Perspective
2018 Standout
Identification of a Core Set of 58 Gene Transcripts With Broad and Specific Expression in the Microvasculature
2008
Cancer Genome Landscapes
2013 StandoutScience
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Recent Advances in Chemoprevention of Cancer
1997 Science
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation
2001 StandoutNobel
A new ligand for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), GW7845, inhibits rat mammary carcinogenesis.
1999
Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture
2000
Identification and functional analysis of endothelial tip cell–enriched genes
2010
Breast Cancer in Men
2002 Standout
Works of Daniel Logsdon being referenced
Genes that Distinguish Physiological and Pathological Angiogenesis
2007
Promotion by polychlorinated biphenyls of lung and liver tumors in mice
1994
Chemoprevention of Mammary Carcinogenesis in the Rat: Combined Use of Raloxifene and 9-cis-Retinoic Acid
1996
1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.
1994
COX-2 Inhibition Potentiates Antiangiogenic Cancer Therapy and Prevents Metastasis in Preclinical Models
2014
Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate.
1995
GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood–brain barrier
2011